Incidence, predictors and clinical outcomes of residual stenosis after aortic valve-in-valve

Autor: Ran Kornowski, Massimo Napodano, Mauricio G. Cohen, Alfredo Giuseppe Cerillo, Sabine Bleiziffer, Stephan Windecker, Tara L. Jones, Eric Horlick, Ankur Kalra, Magdalena Erlebach, Lukas Capek, Vasco Gama Ribeiro, Santiago Garcia, Michael J. Reardon, Sami Alnasser, David Holzhey, Didier Champagnac, Tobias Zeus, Adnan K. Chhatriwalla, Nicolas M. Van Mieghem, Raffi Bekeredjian, Jan Malte Sinning, Isaac George, Rüdiger Lange, Christian J. Rustenbach, Petur Petursson, Matheus Simonato, Enrico Ferrari, Joachim Schofer, Nikolaos Bonaros, John G. Webb, Danny Dvir, Giselle A. Baquero, Philippe Pibarot
Přispěvatelé: Cardiology
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Male
Reoperation
Aortic valve
medicine.medical_specialty
Hemodynamics
030204 cardiovascular system & hematology
Prosthesis Design
Risk Assessment
Body Mass Index
Transcatheter Aortic Valve Replacement
03 medical and health sciences
Postoperative Complications
0302 clinical medicine
Predictive Value of Tests
Risk Factors
Internal medicine
Outcome Assessment
Health Care

Humans
Medicine
030212 general & internal medicine
Adverse effect
610 Medicine & health
Aged
Aged
80 and over

Bioprosthesis
business.industry
Effective orifice area
Incidence
Incidence (epidemiology)
valvular heart disease
Aortic Valve Stenosis
Residual stenosis
medicine.disease
Prosthesis Failure
medicine.anatomical_structure
Echocardiography
Aortic Valve
Heart Valve Prosthesis
Cardiology
Female
Cardiology and Cardiovascular Medicine
business
Body mass index
Zdroj: Heart, 104(10), 828-834. BMJ Publishing Group
ISSN: 1355-6037
DOI: 10.7892/boris.125246
Popis: ObjectiveWe aimed to analyse the incidence of prosthesis–patient mismatch (PPM) and elevated gradients after aortic valve in valve (ViV), and to evaluate predictors and associations with clinical outcomes of this adverse event.MethodsA total of 910 aortic ViV patients were investigated. Elevated residual gradients were defined as ≥20 mm Hg. PPM was identified based on the indexed effective orifice area (EOA), measured by echocardiography, and patient body mass index (BMI). Moderate and severe PPM (cases) were defined by European Association of Cardiovascular Imaging (EACVI) criteria and compared with patients without PPM (controls).ResultsModerate or greater PPM was found in 61% of the patients, and severe in 24.6%. Elevated residual gradients were found in 27.9%. Independent risk factors for the occurrence of lower indexed EOA and therefore severe PPM were higher gradients of the failed bioprosthesis at baseline (unstandardised beta −0.023; 95% CI −0.032 to –0.014; PConclusionsSevere PPM and elevated gradients after aortic ViV are very common but were not associated with short-term survival and clinical outcomes. The long-term effect of poor post-ViV haemodynamics on clinical outcomes requires further evaluation.
Databáze: OpenAIRE